Search Results - "Hippely, Sarah"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Abstract 457: HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts) by Ontiveros, Priscilla, Landaverde, Connie, Levin, Maren K., Hippely, Sarah, Landers, Mark, Wang, Yipeng, Dittamore, Ryan, O'Shaughnessy, Joyce A.

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Background: Upregulation of HER2 and AR protein expression, and increase in chromosomal instability, are mechanisms of acquired resistance to…”
    Get full text
    Journal Article
  2. 2

    Androgen receptor (AR) activation in breast cancer (BC) liver metastases by Ramos, Corinne, Hoke, Nicholas N, Wilks, Tom, Levin, Maren K., Hippely, Sarah, Pierobon, Mariaelena, Petricoin, Emanuel, O'Shaughnessy, Joyce

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only 11619 Background: AR is expressed in the majority of BCs and its signaling may contribute to the development of BC metastases (mets). The…”
    Get full text
    Journal Article
  3. 3

    Phosphoproteomic analysis of matched primary breast cancer (BC) and lymph node (LN) metastases by Ramos, Corinne, Hoke, Nicholas N, Levin, Maren K., Grant, Michael D, Hippely, Sarah, Thamby, Rohan, Pierobon, Mariaelena, Baldelli, Elisa, Snipes, George J, Petricoin, Emanuel, O'Shaughnessy, Joyce

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only 11620 Background: Therapeutic recommendations are often based on molecular markers expressed in primary BCs. However, LN metastases (mets) may…”
    Get full text
    Journal Article
  4. 4